Australia markets close in 3 hours 35 minutes

CNBX Pharmaceuticals Inc. (8C8.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.06900.0000 (0.00%)
At close: 01:39PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 11.76M
Enterprise value 12.01M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)18.34
Enterprise value/revenue N/A
Enterprise value/EBITDA -4.34

Trading information

Stock price history

Beta (5Y monthly) 0.87
52-week change 3-62.70%
S&P500 52-week change 326.27%
52-week high 30.1850
52-week low 30.0605
50-day moving average 30.0716
200-day moving average 30.1095

Share statistics

Avg vol (3-month) 35.71k
Avg vol (10-day) 35.5k
Shares outstanding 5149.44M
Implied shares outstanding 6N/A
Float 827.07M
% held by insiders 10.00%
% held by institutions 110.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Aug 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin -228.09%
Operating margin (ttm)-507.98%

Management effectiveness

Return on assets (ttm)-142.36%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)540.24k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -562.1k
Net income avi to common (ttm)-1.23M
Diluted EPS (ttm)-3.6160
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)37.14k
Total cash per share (mrq)0
Total debt (mrq)1.29M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.06
Book value per share (mrq)-0.08

Cash flow statement

Operating cash flow (ttm)-194.32k
Levered free cash flow (ttm)65.66k